BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND DCTN1, DAP-150, 1639, ENSG00000204843, Q14203, P135, DP-150
7 results:

  • 1. Nomogram to predict malignancy in branch duct type intraductal papillary mucinous neoplasms.
    Xu Y; Xie C; Gao Z; Zhang M; Zhan M
    Medicine (Baltimore); 2022 Sep; 101(38):e30627. PubMed ID: 36197166
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Cohort profile and heritability assessment of familial pancreatic cancer: a nation-wide study.
    Tan M; Brusgaard K; Gerdes AM; Mortensen MB; Detlefsen S; Schaffalitzky de Muckadell OB; Joergensen MT
    Scand J Gastroenterol; 2021 Aug; 56(8):965-971. PubMed ID: 34165379
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. An Oncogenic
    Shimada Y; Kohno T; Ueno H; Ino Y; Hayashi H; Nakaoku T; Sakamoto Y; Kondo S; Morizane C; Shimada K; Okusaka T; Hiraoka N
    Oncologist; 2017 Feb; 22(2):158-164. PubMed ID: 28167572
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Prospective Randomized Controlled Trial of Liberal Vs Restricted Perioperative Fluid Management in Patients Undergoing Pancreatectomy.
    Grant F; Brennan MF; Allen PJ; DeMatteo RP; Kingham TP; D'Angelica M; Fischer ME; Gonen M; Zhang H; Jarnagin WR
    Ann Surg; 2016 Oct; 264(4):591-8. PubMed ID: 27355261
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Safety and pharmacology of gemcitabine and capecitabine in patients with advanced pancreatico-biliary cancer and hepatic dysfunction.
    Joerger M; Huitema AD; Koeberle D; Rosing H; Beijnen JH; Hitz F; Cerny T; Schellens JH; Gillessen S
    Cancer Chemother Pharmacol; 2014 Jan; 73(1):113-24. PubMed ID: 24166106
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Immunohistochemical staining for CDX-2, PDX-1, NESP-55, and TTF-1 can help distinguish gastrointestinal carcinoid tumors from pancreatic endocrine and pulmonary carcinoid tumors.
    Srivastava A; Hornick JL
    Am J Surg Pathol; 2009 Apr; 33(4):626-32. PubMed ID: 19065104
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. PS-341 and gemcitabine in patients with metastatic pancreatic adenocarcinoma: a North Central cancer Treatment Group (NCCTG) randomized phase II study.
    Alberts SR; Foster NR; Morton RF; Kugler J; Schaefer P; Wiesenfeld M; Fitch TR; Steen P; Kim GP; Gill S
    Ann Oncol; 2005 Oct; 16(10):1654-61. PubMed ID: 16085692
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.